Thymus vulgaris ct. thymol is the predominant commercial chemotype of common thyme, characterised by high concentrations of thymol (typically 41-48%) alongside y-terpinene and p-cymene as biosynthetic precursors.^[1] Thymol, a phenolic monoterpenoid, disrupts bacterial membrane integrity and is documented to exert strong activity against both Gram-positive and Gram-negative pathogens, with this chemotype consistently recording the lowest minimum inhibitory concentrations among T. vulgaris chemotypes.^[2] Its high phenolic content also confers substantial antifungal activity, demonstrated against Candida species and dermatophytes in controlled in vitro studies.^[2]